From: TP53 somatic mutations in Asian breast cancer are associated with subtype-specific effects
Overall (n) | Wild-type TP53 (WT) | Mutant TP53 (MT) | p value (groups) | |
---|---|---|---|---|
Subjects [n(%)] 486 | 291 | 195 | ||
Age at diagnosis (yr) 53.1 ± 11.5 | 53.3 ± 11.4 | 52.8 ± 11.7 | 0.61 | |
Histological subtype [n(%)] | ||||
Invasive ductal carcinoma | 437 | 258 (59.0) [88.7] | 179 (41.0) [91.8] | 0.34 |
Invasive lobular carcinoma | 17 | 16 (94.1) [5.5] | 1 (5.9) [0.5] | 3.1E−03 |
Other | 14 | 5 (35.7) [1.7] | 9 (64.3) [4.7] | 0.064 |
Unknown | 18 | 12 (66.7) [4.1] | 6 (33.3) [3.1] | |
PAM50 subtypes [n(%)] | ||||
Luminal A | 178 | 152 (85.4) [52.2] | 26 (14.6) [13.3] | < 2E−16 |
Luminal B | 97 | 67 (69.1) [23.0] | 30 (30.9) [15.4] | 0.047 |
HER2-enriched | 105 | 36 (34.3) [12.4] | 69 (65.7) [35.4] | 3.0E−09 |
Basal-like | 92 | 30 (32.6) [10.3] | 62 (67.4) [31.8] | 6.3E−09 |
Normal-like | 14 | 6 (42.9) [2.1] | 8 (57.1) [4.1] | 0.19 |
Tumour stage [n(%)] | ||||
0–1 | 83 | 51 (61.4) [17.5] | 32 (38.6) [16.4] | 0.73 |
2 | 221 | 136 (61.5) [46.7] | 85 (38.5) 43.6] | 0.45 |
3 | 147 | 80 (54.4) [27.5] | 67 (45.6) [34.4] | 0.11 |
4 | 16 | 12 (75.0) [4.1] | 4 (25.0) [2.1] | 0.21 |
Unknown | 19 | 12 (63.2) [4.1] | 7 (36.8) [3.6] | |
Tumour grade [n(%)] | ||||
1 | 11 | 11 (100) [3.8] | 0 (0) [0] | 0.021 |
2 | 208 | 160 (76.9) [55.0] | 48 (23.1) [24.7] | 6.1E−12 |
3 | 232 | 98 (42.2) [33.7] | 134 (57.8) [68.7] | 1.0E−13 |
Unknown | 35 | 22 (62.9) [7.6] | 13 (37.1) [6.7] |